The Enterprise Value as of December 2025 (TTM) for Fulcrum Therapeutics, Inc. (FULC) is 433.95M

According to Fulcrum Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 433.95M. This represents a change of 35.51% compared to the average of 320.24M of the last 4 quarters.

Fulcrum Therapeutics, Inc. (FULC) Historical Enterprise Value (quarterly & annually)

How has FULC Enterprise Value performed in the past?

The mean historical Enterprise Value of Fulcrum Therapeutics, Inc. over the last ten years is 309.50M. The current 433.95M Enterprise Value has changed 13.92% with respect to the historical average. Over the past ten years (40 quarters), FULC's Enterprise Value was at its highest in in the September 2021 quarter at 967.18M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Fulcrum Therapeutics, Inc. (FULC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fulcrum Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fulcrum Therapeutics, Inc. (FULC) Average Enterprise Value

How has FULC Enterprise Value performed in the past?

The current Enterprise Value of Fulcrum Therapeutics, Inc. (FULC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fulcrum Therapeutics, Inc. (FULC) Enterprise Value vs. Peers

How is FULC’s Enterprise Value compared to its peers?

Fulcrum Therapeutics, Inc.’s Enterprise Value is greater than Ocugen, Inc. (393.09M), less than Compass Therapeutics, Inc. (719.89M), less than Lexicon Pharmaceuticals, Inc. (556.11M), less than Omeros Corporation (883.69M), less than RAPT Therapeutics, Inc. (534.71M), greater than Neumora Therapeutics, Inc. Common Stock (251.41M), greater than Bicycle Therapeutics plc (-152624053.00), greater than Lineage Cell Therapeutics, Inc. (362.42M), greater than ADC Therapeutics S.A. (262.56M), greater than Neurogene Inc. (266.96M),

Build a custom stock screener for Fulcrum Therapeutics, Inc. (FULC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fulcrum Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fulcrum Therapeutics, Inc. (FULC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fulcrum Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.